Production (Stage)
Fractyl Health, Inc.
GUTS
$2.06
-$0.11-5.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.95% | -7.75% | -34.50% | -418.63% | 82.68% |
| Total Depreciation and Amortization | 30.04% | 6.70% | 8.85% | 262.26% | 39.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -90.30% | -1.66% | 474.39% | 93.75% | -262.12% |
| Change in Net Operating Assets | -138.12% | 132.00% | 324.11% | -128.00% | 187.32% |
| Cash from Operations | -47.23% | 5.57% | 3.73% | -59.99% | -10.49% |
| Capital Expenditure | -92.27% | -9.39% | 18.08% | 75.45% | -678.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -92.27% | -9.39% | 18.08% | 75.45% | -678.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.83% | -82.76% | -176.19% | -950.00% | 33.33% |
| Issuance of Common Stock | 61.85% | -21.36% | 1,275.00% | -99.98% | 610,829.41% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -400.70% |
| Cash from Financing | 155.22% | -58.64% | 3,340.00% | -100.00% | 18,265.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -47.42% | 4.92% | 4.80% | -121.54% | 881.44% |